Chloroprocaine

This classification denotes an anesthetic agent with the molecular formula C13H19ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5YVB0POT2H, chemically known as benzoic acid, 4-amino-2-chloro-, 2-(diethylamino)ethyl ester but generally known as chloroprocaine, which bears US NIH Compound Identifier 8612. European Medicines Agency schedules Chloroprocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06193MIG. The term CHLOROPROCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules chloroprocaine in its Anatomical Therapeutic Chemical (ATC) Classification. CHLOROPROCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chloroprocaine under HS 29224995 and SITC 51465. As of Q4 2014, CHLOROPROCAINE remains the US FDA Preferred Term for this commodity. Chloroprocaine bears US NLM identifiers UMLS ID C0055443 and NCI Concept Code C72168. SMILES: CLC1C(C(=O)OCCN(CC)CC)CCC(N)C1.